Abstract
Herein we report on a new series of hydrazidoureidobenzensulfonamides investigated as inhibitors of the cytosolic human (h) hCA I and II isoforms, as well as the transmembrane, tumor-associated enzymes hCA IX and XII. The reported derivatives contain a 4-substituted piperidine fragment in which the hydrazidoureido linker has been involved as spacer between the benzenesulfonamide fragment which binds the zinc ion from the active site, and the tail of the inhibitor. Depending on the substitution pattern at the piperidine ring, low nanomolar inhibitors were detected against hCA II, hCA IX and hCA XII, making the new class of sulfonamides of interest for various pharmacologic applications.
Keywords:
Antitumor; Inhibitor; Metalloenzyme; Selectivity; Sulfonamides.
Copyright © 2020 Elsevier Inc. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antigens, Neoplasm / metabolism
-
Benzenesulfonamides
-
Carbonic Anhydrase II / antagonists & inhibitors
-
Carbonic Anhydrase II / metabolism
-
Carbonic Anhydrase IX / antagonists & inhibitors
-
Carbonic Anhydrase IX / metabolism
-
Carbonic Anhydrase Inhibitors / chemical synthesis
-
Carbonic Anhydrase Inhibitors / chemistry
-
Carbonic Anhydrase Inhibitors / pharmacology*
-
Carbonic Anhydrases / metabolism
-
Dose-Response Relationship, Drug
-
Humans
-
Hydrazines / chemistry
-
Hydrazines / pharmacology*
-
Molecular Docking Simulation*
-
Molecular Structure
-
Piperidines / chemistry
-
Piperidines / pharmacology*
-
Structure-Activity Relationship
-
Sulfonamides / chemistry
-
Sulfonamides / pharmacology*
Substances
-
Antigens, Neoplasm
-
Carbonic Anhydrase Inhibitors
-
Hydrazines
-
Piperidines
-
Sulfonamides
-
piperidine
-
Carbonic Anhydrase II
-
CA9 protein, human
-
Carbonic Anhydrase IX
-
Carbonic Anhydrases
-
carbonic anhydrase XII